Sri Tasminatun,M.Si.,Apt
LO
🞂Mahasiswa mampu menjelaskan Jenis obat, Sifat
Fisiko-kimia, Indikasi, Kontra Indikasi,
Farmakokinetik, ADR, Interaksi obat, Toksisitas,
Sediaan lazim, brand name, penyimpanan obat-obat
yang bekerja pada saluran cerna : Antasida,
antiulserasi, antirefluks, regulator GIT, antiflatulen,
Antiemetika, antispasmodik
antasida
🞂Aludonna D : Mg (OH) 2 200 mg ,Al(OH) 3 200 mg,
simethicon 20 mg (tablet kunyah ; suspensi)
🞂 Omeprazole
⮚Gastrofer : injeksi 40 mg
⮚Lanazer : kapsul 20 mg
🞂 Pantoprazol Na
Ziprazol / Erprazol : injeksi 40 mg
Esomeprazol
◦ Exoid /esoferr injeksi 40 mg
Comparison of lansoprazole (30 mg) and omeprazole (20 mg)
in the treatment of duodenal ulcer. A multicenter double-
blind comparative trial].
🞂 Petite JP1, Slama JL, Licht H, Lemerez M, Coste T, Andrieu J, Grimaud JC, Julien H, Dupuis J,
Sallerin V.
🞂 The efficacy of lansoprazole (30 mg/d) and omeprazole (20 mg/d) has been
assessed in active duodenal ulcer disease in 144 patients included in a multicentric,
randomized, double-blind trial. After two weeks, the healing rates were 74% and
58% in the lansoprazole and omeprazole groups, respectively (P = 0.049). After 4
weeks, the healing rates were 94% in each group (NS). The delay to pain relief was
2 days for lansoprazole and 3 days for omeprazole (NS). Minor side effects
occurred in 12% of the lansoprazole treated patients and in 13% of the omeprazole
treated patients. No severe adverse events were reported. A slight increase in serum
gastrin level was observed, similar in both groups (+35 UI/L and +19 UI/L for
lansoprazole and omeprazole respectively). This study confirms previous results
concerning the efficacy of both treatments in duodenal ulcer disease. The statistical
difference observed for healing rates after 2 weeks could correspond to a faster
efficacy for lansoprazole (30 mg) than for omeprazole (20 mg).
Ranitidine HCl
🞂Acran : tab 150 mg, kaplet 300 mg
🞂Ranin : tab 150 mg injeksi 25 mg/ml (2 ml)
🞂Ranivel : tab 150 mg ; syr 75 mg/5ml, inj 25
mg/ml(2ml)
❑Famotidin
🞂Famocid : Famotidine 20 mg , 40 mg
🞂Ulcerid ; famotidine 20 mg , 40 mg
❑Cimetidine
▪ Ulcikur : tab 200 mg, 400 mg , injeksi 200 mg/ml
▪ Ulcumet tab 200 mg, injeksi 100 mg/ml
❑sucralfat
🞂 Musin tab/ suspensi
500 mg / tablet; 500 mg / 5 ml suspensi
❑ Cytotex
Regulator GIT, antiflatulen
🞂Budesonide
◦ Budenofalk : kapsul 3 mg
🞂Cisapride
◦ acpulsif /Disflux : tab 5 mg
🞂Domperidon
◦ Vometa tab 10 mg
◦ Vometa sirup 1mg/ml, tetes 5 mg /ml
◦ Vomidone : suspensi 5 mg/5 ml; tetes oral 5mg/ml
Budesonide
🞂 Indikasi
Obat untuk mengendalikan gejala penyakit radang usus,
seperti Penyakit Crohn dan kolitis ulserativa
Indikasi:
🞂Dewasa: untuk mengatasi gangguan motilitas
gastrointestinal, khususnya gastroparesis. Anak-anak:
untuk refluks gastroesofagal berat, apabila terapi lain
tidak berhasil.
🞂Acpulsif
🞂Guarposid
domperidone
🞂Menyekat reseptor dopaminergik di CTZ
🞂Meningkatkan motilitas saluran cerna
🞂Mual muntah karena opium, bedah, radiasi,
kemoterapi, gangguan saluran cerna
🞂ESO : ekstrapiramidal, lemah, pusing letih, diare
Anti spamodik
🞂Hyoscine N-butylbromide
◦ Hyoscopan / Scopamin / Spashi : tablet salut gula 10 mg
◦ Scopamin plus /Spashi plus : Hyoscine N-butylbromide 10
mg + parasetamol 500 mg